Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON43999Recruiting
Randomised, open-label trial of cefazolin in acute calculous cholecystitis (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Composite postoperative infectious complications within 30 days. Started Mar 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON43999.